Bellevue Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-13
Closed -$2K 560
2021
Q4
$2K Sell
13
-1
-7% -$154 ﹤0.01% 507
2021
Q3
$2K Buy
+14
New +$2K ﹤0.01% 533